Defects in the homologous recombination (HR) repair pathway are of clinical interest due to sensitivity of HR-deficient cells to PARP inhibitors. We were interested in defining PARP vulnerability in patients with metastatic colorectal cancer (mCRC) carrying KRAS and BRAF mutations who display poor prognosis, have limited therapeutic options, and represent an unmet clinical need.

A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin

Arena, Sabrina
First
;
Corti, Giorgio;Russo, Mariangela;Lorenzato, Annalisa;Arcella, Pamela;Rospo, Giuseppe;Pagani, Massimiliano;Negrino, Carola;Isella, Claudio;Mittica, Gloria;Medico, Enzo;Di Nicolantonio, Federica;Bardelli, Alberto
Last
2019-01-01

Abstract

Defects in the homologous recombination (HR) repair pathway are of clinical interest due to sensitivity of HR-deficient cells to PARP inhibitors. We were interested in defining PARP vulnerability in patients with metastatic colorectal cancer (mCRC) carrying KRAS and BRAF mutations who display poor prognosis, have limited therapeutic options, and represent an unmet clinical need.
2019
1
14
Arena, Sabrina; Corti, Giorgio; Durinikova, Erika; Montone, Monica; Reilly, Nicole M; Russo, Mariangela; Lorenzato, Annalisa; Arcella, Pamela; Lazzari...espandi
File in questo prodotto:
File Dimensione Formato  
1078-0432.CCR-19-2409.full.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 1.04 MB
Formato Adobe PDF
1.04 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
1078-0432.CCR-19-2409.full.pdf

Accesso aperto

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 11.58 MB
Formato Adobe PDF
11.58 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1728652
Citazioni
  • ???jsp.display-item.citation.pmc??? 47
  • Scopus 70
  • ???jsp.display-item.citation.isi??? 67
social impact